Machibya Musa, Damji Bhavish, Adamjee Shabbir, Kyejo Willbroad, Njau Aidan, Ngimba Caroline
Department of General Surgery, The Aga Khan University, P. O Box 38129, Dar Es Salaam, Tanzania.
Department of General Surgery, The Aga Khan University, P. O Box 38129, Dar Es Salaam, Tanzania.
Int J Surg Case Rep. 2025 Mar;128:111087. doi: 10.1016/j.ijscr.2025.111087. Epub 2025 Feb 27.
Introduction and Importance. Small bowel lymphomas, which represent <1 % of gastrointestinal cancers, are most found in the ileum due to its high concentration of gut-associated lymphoid tissue. T-cell lymphomas of the small bowel are particularly rare. While increased risk is noted in conditions like celiac disease and immunodeficiency, their occurrence in HIV/AIDS patients is uncommon and poorly understood. The rare complication of gastrointestinal perforation in these cases complicates diagnosis and management.
42-year-old woman with HIV/AIDS, on antiretroviral therapy for 4 years, presented with a 1-month history of progressively worsening abdominal pain, intermittent fevers, weight loss, and a productive cough. On physical examination, she was cachectic, febrile, and had generalized abdominal tenderness with signs of peritonism. Laboratory investigations revealed anemia, elevated CRP, and ESR, with a CD4 count of 441 cells/mcL. Imaging studies, including abdominal CT, showed free air and fluid suggestive of a perforated viscus. The patient underwent emergency laparotomy, which revealed multiple bowel perforations. Resection was performed, and histopathology confirmed small bowel T-cell lymphoma (anaplastic large cell lymphoma). Despite intensive postoperative care, the patient died on the fourth postoperative day.
Small bowel T-cell lymphoma is rare, especially in HIV/AIDS patients, and poses significant diagnostic challenges. Its presentation is often nonspecific, and perforation is a serious complication. While chemotherapy and surgery are key treatments, T-cell lymphomas are more resistant to therapy, leading to a poor prognosis, particularly when complicated by perforation.
This case highlights the rarity and complexity of small bowel T-cell lymphoma in HIV/AIDS, compounded by gastrointestinal perforation. Early diagnosis, advanced imaging, and multidisciplinary management are essential for improving outcomes. Further research is needed to optimize treatment strategies for this challenging case.
引言与重要性。小肠淋巴瘤占胃肠道癌症的比例不到1%,由于回肠中肠道相关淋巴组织高度集中,因此最常发生于回肠。小肠T细胞淋巴瘤尤为罕见。虽然在乳糜泻和免疫缺陷等情况下风险会增加,但它们在HIV/AIDS患者中的发生并不常见,且了解甚少。这些病例中罕见的胃肠道穿孔并发症使诊断和管理变得复杂。
一名42岁的HIV/AIDS女性,接受抗逆转录病毒治疗4年,出现了1个月来逐渐加重的腹痛、间歇性发热、体重减轻和咳痰症状。体格检查发现她消瘦、发热,全腹压痛并有腹膜炎体征。实验室检查显示贫血、C反应蛋白和红细胞沉降率升高,CD4细胞计数为441个/微升。包括腹部CT在内的影像学检查显示有游离气体和液体,提示存在脏器穿孔。患者接受了急诊剖腹手术,术中发现多处肠穿孔。进行了切除手术,组织病理学证实为小肠T细胞淋巴瘤(间变性大细胞淋巴瘤)。尽管术后进行了 intensive care,患者仍在术后第四天死亡。
小肠T细胞淋巴瘤很罕见,尤其是在HIV/AIDS患者中,并且带来了重大的诊断挑战。其表现通常不具有特异性,穿孔是一种严重的并发症。虽然化疗和手术是关键治疗方法,但T细胞淋巴瘤对治疗更具抗性,导致预后不良,尤其是在并发穿孔时。
本病例突出了HIV/AIDS患者中小肠T细胞淋巴瘤的罕见性和复杂性,再加上胃肠道穿孔。早期诊断、先进的影像学检查和多学科管理对于改善预后至关重要。需要进一步研究以优化针对这一具有挑战性病例的治疗策略。